In summary, the findings from the present study suggest that COX-2 in the PVN may be an intermediary step for PVN neuronal activation and excitatory neurotransmitter release, which further contributes to sympathoexcitation and RAS activation in adriamycin-induced heart failure. Here, PTGS2 is linked to heart failure.